Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01153035

Excision Followed by Radiofrequency Ablation for Breast Cancer

ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
Female
Age
50 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequency AblationBreast conservation surgery followed by Radiofrequency Ablation of the cavity

Timeline

Start date
2010-06-01
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2010-06-29
Last updated
2025-11-10

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01153035. Inclusion in this directory is not an endorsement.

Excision Followed by Radiofrequency Ablation for Breast Cancer (NCT01153035) · Clinical Trials Directory